Treating age-related diseases to extend health-span
Joined December 2020
- Tweets19
- Following70
- Followers187
- Likes16
Rubedo Life Sciences retweeted
Sharing the latest from @NatureNeuro journal:
Our computational work at @LifeRubedo in collaboration with leading scientists from @StanfordMed is featured on the cover.
Grateful for the opportunity to contribute to such impactful work in a small capacity.
nature.com/articles/s41593-0…
We’re excited to announce a major milestone at Rubedo Life Sciences: our first patients have been dosed!
With this, Rubedo officially enters the clinic as a clinical-stage longevity biotech.
businesswire.com/news/home/2…
breakthrough discovery: featured on the cover, our new paper on Nature Neuroscience with Prof. Tawfik lab at Stanford University, showing first-in-class senescence sensory neurons to treat neuropathic pain
businesswire.com/news/home/2…
We are excited to announced a strategic partnership with @Beiersdorf_AG to advance the skincare industry with a disruptive and innovative product, born from deep science of aging and cellular senescence biology businesswire.com/news/home/2…
We are stocked to announced that we closed our $40M+ Series A led by @khoslaventures and Ahren Innovation capital to advance the company to the clinic with our first program, entry point to broader therapeutic areas of chronic diseases of aging businesswire.com/news/home/2…
Rubedo Life Sciences retweeted
💣New investment for IAG #businessangels: @LifeRubedo
👩🔬 #biopharmaceuticals Rubedo Life Sciences secures a substantial $40M Series A financing round, with a focus on advancing groundbreaking therapies targeting age-related diseases.
italianangels.net/en/news/ne…
Rubedo Life Sciences retweeted
.@LifeRubedo just brought in $40 million in a series A financing round co-led by @khoslaventures and Ahren Innovation Capital. The start-up will develop medicines for aging cells that drive skin and fibrotic diseases: cen.acs.org/business/start-u…
Rubedo Life Sciences retweeted
Rubedo lands $40m to advance senescence-targeting therapeutics into clinical trials...
Longevity biotech @LifeRubedo plans Phase 1 #senotherapeutics trial this year as it seeks to keep people ‘biologically young.’
#longevity #investment #senescence
longevity.technology/news/ru…
Celebrating with @khoslaventures team and Rubedo team our Series A and the partnering deal with @Beiersdorf_AG
Rubedo Life Sciences retweeted
We are excited to share the report of the Seno-Therapeutics Summit 2023.
You can read the paper now published on Nature Portfolio journal npj #aging by Summit chairs Dr. Marco Quarta, our President, and Dr. Marco Demaria, our Chairman of the SAB.
nature.com/articles/s41514-0…
Rubedo Life Sciences retweeted
@PhaedonInstitut is hosting a Senotherapeutics Summit at Buck on Nov 7-8. Fantastic line up of speakers and panelists all focused on #senescence.
Register here: phaedon.institute/summit/reg…
#phaedoninstitute #senotherapeuticsummit2023 #longevity
Rubedo Life Sciences retweeted
"There are no competitors in senotherapeutics – we are all collaborators."
Great article by @LongevityTech discussing the upcoming #SenoTherapeuticsSummit with our President @MarcoQuarta12!
‘There are no competitors in #senotherapeutics – we are all collaborators’
Ahead of next month’s key #SenoTherapeuticsSummit, we talk to Dr Marco Quarta
@PhaedonInstitut
longevity.technology/news/th…
The RIse of Longevity Therapeutics - nice article on Pharma Exec by Dr. @Marco4Quarta12 CEO & CoFounder of Rubedo pharmexec.com/view/the-rise-…
Rubedo Life Sciences retweeted
TODAY: @bioagelabs CEO @kpfortney joins a Clubhouse Q&A about the @beOnDeck Longevity Biotech Fellowship. ODLB brings people together to build, join, and invest in revolutionary longevity biotechnology startups!
Monday, July 12, 10:30 AM PDT
clubhouse.com/event/Mwab7e2B
Be sure to check out the latest @PrimeMoversLab webinar on Wednesday at 12:00 PT/3:00 ET exploring the technologies that are helping us live longer and the startups making the biggest breakthroughs.
Register here: bit.ly/3e4XmWy
